Q3 FY2026 · ended Sep 30, 2026 · Revenue $5.51B, +7.2% YoY · Filed Oct 28, 2026
Ge Healthcare Technologies Inc. (GEHC) files with the SEC under industry code 3844, X-Ray Apparatus & Tubes & Related Irradiation Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $5.5 billion and net income of $615.0 million. Free cash flow was $793.0 million. As of Sep 30, 2026 it held $3.2 billion in cash and investments and $10.4 billion in total debt.
Company profile
- Industry
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844)
- Listed as
- GEHC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Chicago, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1932393
- Former names
- GE Healthcare Holding LLC (until Dec 14, 2022)
Other X-Ray Apparatus & Tubes & Related Irradiation Apparatus companies
- Koninklijke Philips NV PHG
- Butterfly Network, Inc. BFLY
- Nano-X Imaging Ltd. NNOX
All 4 X-Ray Apparatus & Tubes & Related Irradiation Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $5.5B | $5.3B | $5.1B | $5.7B | $5.1B |
| Operating income | $805.0M | $739.0M | $515.0M | $827.0M | $653.0M |
| Net income | $615.0M | $561.0M | $389.0M | $589.0M | $446.0M |
| Diluted EPS | $1.36 | $1.24 | $0.85 | $1.29 | $0.98 |
| Operating cash flow | $907.0M | $168.0M | $290.0M | — | — |
| Free cash flow | $793.0M | $68.0M | $112.0M | — | — |
| Total assets | $38.4B | $37.2B | $37.1B | $36.9B | $36.1B |
| Total liabilities | $26.5B | $26.0B | $26.2B | $26.3B | $25.9B |
| Stockholders' equity | $11.6B | $11.0B | $10.7B | $10.4B | $10.0B |
| Cash and investments | $3.2B | $2.4B | $2.6B | $4.8B | $4.3B |
| Total debt | $10.4B | $10.5B | $10.6B | $11.0B | $12.7B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Nov 5, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Oct 28, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 18, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 29, 2026 | Jul 29, 2026 |
All 446 Ge Healthcare Technologies Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.